R
Richard S. Crow
Researcher at National Institutes of Health
Publications - 3
Citations - 528
Richard S. Crow is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Exercise physiology & Randomized controlled trial. The author has an hindex of 3, co-authored 3 publications receiving 518 citations.
Papers
More filters
Journal ArticleDOI
Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus: Early Treatment Diabetic Retinopathy Study Report 14
Aaron Kassoff,Sheldon M. Buzney,J. Wallace McMeel,John J. Weiter,Gerald J. Doyle,Rodney L. Immerman,Gerald R. Friedman,Michael L. Klein,Richard F. Dreyer,Richard Chenoweth,Irvin Handelman,Richard Hohl,Robert Biesbroeck,Jack O. Sipperley,Charles A. Garcia,Michael A. Bloome,Richard S. Ruiz,F. Tempel Riekhof,William A. Bohart,Roy A. Goodart,Dana H. Clarke,David H. Orth,Timothy P. Flood,Kirk H. Packo,Jayant Malhotra,Akbar Rahmani,Edward J. Winter,Harish Bhatia,Robert P. Murphy,Stuart L. Fine,Michael J. Elman,Frederick L. Ferris,Thaddeus E. Prout,Arnall Patz,Thomas A. Rice,David Newsome,Lloyd M. Aiello,Lawrence I. Rand,S. Shah,Ramachandiran Cooppan,Jerry Cavallerano,Robert L. Poole,Philip Silver,Jose Briones,Mohammed Z. Wafai,Abdul C. Asmal,Rudolph M. Franklin,Laurence Arend,Donald Bergsma,Lance Turkish,Paul Beer,Denis Carroll,Edgar Thomas,Thomas C. Burton,Gary W. Abrams,Hak-Joong Kim,George A. Williams,Trexler M. Topping,Frederick H. Reeser,Thomas M. Aaberg,Gregory S. Brinton,James K. Kingham,Travis A. Meredith,Raymond R. Margherio,Patrick L. Murphy,Morton S. Cox,Michael T. Trese,Steven Winokur,Everett Ai,Robert Sorenson,Gary Arsham,John Cavender,Stanley M. Kopelow,Alan L. Shabo,Jose C. Briones,Richard D. Hornichter,Norman P. Blair,Morton F. Goldberg,C. Ronald Lindberg,Neil L. Ross,Lynn E. Hauser,Jose Cunha-Vaz,J. Terry Ernest,James C. Liang,Steven B. Cohen,Charles Vygantas,Gerald A. Williams,Harry W. Flynn,George W. Blankenship,William H. Knobloch,Robert C. Ramsay,Herbert L. Cantrill,Frederick C. Goetz,Byron J. Hoogwerf,José Berrocal,Raúl Pérez,A. Ramos Umpierre,James L. Kinyoun,Robert E. Kalina,Craig G. Wells,Steven V. Guzak,Jerry P. Palmer,Frank L. Myers,George H. Bresnick,Suresh R. Chandra,Matthew D. Davis,Ronald Klein,Thomas S. Stevens,Ingolf H. L. Wallow,Russell M. Dixon,Edward Ehrlich,Robin Ewart,Robert N. Frank,Stephenie Lucas,Fred W. Whitehouse,Harold B. Weiss,Ann E. Ballen,Michael Teske,Maria Warth,William E. Benson,William S. Tasman,Gary C. Brown,J. Archibald McNamara,Hunter L. Little,Robert L. Jack,Lawrence Basso,Dayton T. Miller,Elaine W. Gunter,David D. Bayse,W. Harry Hannon,James E. Myrick,Genell L. Knatterud,Marian R. Fisher,Mary Jane Prior,Franca Barton,Joseph A. Kufera,Thomas W. Miller,James K. Hooper,Richard S. Crow,Richard Baker,Ronald J. Prineas,Larry D. Hubbard,Yvonne L. Magli,Paul Segal,Richard L. Mowery,Emily Y. Chew,Daniel Seigel,Gary Cassel +147 more
TL;DR: The early treatment diabetic retinopathy study (ETDRS) as mentioned in this paper was a randomized clinical trial of aspirin vs placebo, which was sponsored by the National Eye Institute (NIEI).
Journal ArticleDOI
Persistence of Reduction in Blood Pressure and Mortality of Participants in the Hypertension Detection and Follow-up Program
Neil Shulman,Elbert Tuttle,George Entwisle,Aristide Apostolides,Albert Oberman,Harold W. Schnaper,Edward H. Kass,James O. Taylor,B. Frank Polk,Jeremiah Stamler,Rose Stamler,Flora C. Gosch,Nemat O. Borhani,Beth Newman,Linda C. Harlan,Marshall Lee,Jack W. Jones,Sandra A. Daugherty,H. A. Tyroler,Curtis G. Hames,Siegfried Heyden,Lawrence M. Slotkoff,Socrates Fotiu,Herbert G. Langford,John Abernathy,Myra Tyler,Morton H. Maxwell,Andrew Lewin,Roger Detels,Reuben Berman,Ronald J. Prineas,Richard S. Crow,M. Donald Blaufox,Sylvia Wassertheil-Smoller,C. Hilmon Castle,Josephine Kasteller,C. Morton Hawkins,Charles E. Ford,Barry R. Davis,Agostino Molteni,Kenneth A. Schneider,Edward J. Fitzsimmons,Gerald H. Payne,Thomas P. Blaszkowski,William J. Zukel,Alvin P. Shapiro,Glenn E. Bartsch,Kenneth G. Berge,Edward S. Cooper,Edward D. Frohlich,Richard H. Gadsden,David L. Sackett,Joseph A. Wilber,W. McFate Smith,Walter M. Kirkendall,Curtis L. Meinert,Louis S. Monk,Richard D. Remington,Max Halperin +58 more
TL;DR: The absolute mortality advantage found at 6.7 years persisted and increased throughout the posttrial period of follow-up despite discontinuation of the formal SC therapy program, postulated that regression of hypertensive end-organ changes brought about by the more effective SC treatment caused this favorable outcome.
Journal ArticleDOI
Validity of Ratings of Perceived Exertion in Patients with Type 2 Diabetes.
Jessica L. Unick,Sarah A. Gaussoin,Judy Bahnson,Richard S. Crow,Jeffrey R. Curtis,Tina Killean,Judith G. Regensteiner,Kerry J. Stewart,Rena R. Wing,John M. Jakicic +9 more
TL;DR: RPE appropriately gauges exercise intensity in approximately half of overweight individuals with type 2 diabetes; however, more than one-third of participants were at an increased risk of exercising at a higher than prescribed intensity when using RPE.